SERALC INVESTMENT CORPORATION has been set up 10/10/1980 in state FL.
The current status of the business is Inactive. The SERALC INVESTMENT CORPORATION principal address is % BIOTEST DIAGNOSTICS CORP., 66 FORD ROAD, SUITE 131, DENVILLE, NJ, 07834.
Meanwhile you can send your letters to % BIOTEST DIAGNOSTICS CORP., 66 FORD ROAD, SUITE 131, DENVILLE, NJ, 07834.
The company`s registered agent is UNITED STATES CORPORATION COMPANY 110 NORTH MAGNOLIA STREET, TALLAHASSEE, FL, 32301.
The company`s management are Director - Schleussner Dr Hans, President - Walger Harro D, Secretary, Treasurer - Schenk Alexander H. The last significant event in the company history is VOLUNTARY DISSOLUTION which is dated by 11/8/2000. This decision is take in action on unknown. The company annual reports filed on Annual reports – 4/20/2000.
Company number F01373
Status Inactive
FEI number 592030591
Company Type Domestic for Profit
Home State FL
Last activity date 11/8/2000
Date Of Incorporation 10/10/1980
Principal Address
% BIOTEST DIAGNOSTICS CORP., 66 FORD ROAD, SUITE 131, DENVILLE, NJ, 07834
Mailing Address % BIOTEST DIAGNOSTICS CORP., 66 FORD ROAD, SUITE 131, DENVILLE, NJ, 07834
SERALC INVESTMENT CORPORATION Principals
Schleussner Dr Hans
Director
Schleussner Dr Hans
Address
600 FRANKFURT-AM-MAIN, WEST GERMANY
Harro D Walger
President
Walger Harro D
Address
66 FORD ROAD, DENVILLE, NJ, 07834
Schenk Alexander H
Secretary, Treasurer
Schenk Alexander H
Address
66 FORD ROAD, DENVILLE, NJ
Last Annual Reports
2000 4/20/2000
2000 4/20/2000
1999 5/6/1999
Registered Agent
Agent Name UNITED STATES CORPORATION COMPANY (c)
Agent Address
110 NORTH MAGNOLIA STREET, TALLAHASSEE, FL, 32301
SERALC INVESTMENT CORPORATION Events
11/8/2000 VOLUNTARY DISSOLUTION
Florida